Valsartan and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Valsartan (valsartan), especially for people who are female, 60+ old, also take Metformin, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Valsartan. It is created by eHealthMe based on reports of 62,763 people who have side effects when taking Valsartan from the FDA, and is updated regularly.

What is Valsartan?

Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,641 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

On May, 02, 2026

62,763 people reported to have side effects when taking Valsartan.
Among them, 25 people (0.04%) have Type 1 diabetes.

Among these 25 people:

What is the gender of people who have Type 1 diabetes when taking Valsartan? *

female: 64 %
male: 36 %

What is the age of people who have Type 1 diabetes when taking Valsartan? *

What are other drugs people take besides Valsartan? *

What are other side effects people have besides Type 1 diabetes? *

Diabetes: 7 people, 28.00%
Blood Glucose Increased: 7 people, 28.00%
Decreased Immune Responsiveness: 5 people, 20.00%
Dermatitis Exfoliative Generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface): 5 people, 20.00%
Hepatic Enzyme Increased: 5 people, 20.00%
Drowsiness: 5 people, 20.00%
Mobility Decreased (ability to move is reduced): 5 people, 20.00%
Drug Ineffective: 5 people, 20.00%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 20.00%
Fatigue (feeling of tiredness): 5 people, 20.00%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 24.00%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 20.00%
Pain: 4 people, 16.00%
Impaired Gastric Emptying: 2 people, 8.00%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 8.00%
Cardiac Disorder: 2 people, 8.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 8.00%
High Blood Cholesterol: 2 people, 8.00%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 8.00%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Valsartan and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valsartan:

Valsartan (63,805 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,845 reports)

Browse all side effects of Valsartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (668 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,641 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valsartan (the active ingredients of Valsartan) and Valsartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.